168 results
DEFA14A
NBSE
NeuBase Therapeutics Inc
6 May 24
Additional proxy soliciting materials
7:30am
Materials
Soliciting Material under §240.14a-12
NeuBase Therapeutics, Inc.
(Name of Registrant as Specified In Its Charter)
(Name of Person(s) Filing … with preliminary materials.
Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11.
NEUBASE THERAPEUTICS, INC
8-K
NBSE
NeuBase Therapeutics Inc
7 Mar 24
Other Events
4:01pm
to be announced to seek approval of the liquidation and dissolution of the Company and the Plan of Dissolution and will file proxy materials relating … statement and other relevant materials with the SEC. The definitive proxy statement will be sent to the Company's stockholders and will contain
8-K
NBSE
NeuBase Therapeutics Inc
23 Feb 24
Other Events
4:01pm
materials relating to the Special Meeting with the Securities and Exchange Commission (the “SEC”). A copy of the Plan of Dissolution will be filed … with such proxy materials. The Board reserves the right to abandon the proposed liquidation and dissolution and the Plan of Dissolution, even if approved
8-K
EX-10.1
28va01rzd7r0
26 Jan 24
Entry into a Material Definitive Agreement
8:00am
8-K
EX-10.1
cqo0rh0r t4hw
18 Oct 23
Entry into a Material Definitive Agreement
8:00am
DEFA14A
334houpizwy5ybgzw
18 Sep 23
Additional proxy soliciting materials
4:20pm
DEFA14A
peudcz93aoy zo
11 Aug 23
Additional proxy soliciting materials
6:18am
8-K
yx5 hpehu6weco
3 Aug 23
NeuBase Therapeutics to Explore Strategic Alternatives
7:05am
8-K
EX-10.3
8oz8 tpbpda8hqznz9
30 Jun 23
NeuBase Announces $5 Million Concurrent Registered Direct Offering and Private Placement Priced At-the-Market Under Nasdaq Rules
4:21pm
8-K
EX-10.2
ga4uz2hsp0bqnao9l8
30 Jun 23
NeuBase Announces $5 Million Concurrent Registered Direct Offering and Private Placement Priced At-the-Market Under Nasdaq Rules
4:21pm
8-K
EX-10.1
ncawufxl
30 Jun 23
NeuBase Announces $5 Million Concurrent Registered Direct Offering and Private Placement Priced At-the-Market Under Nasdaq Rules
4:21pm
424B5
sxty95 5eog
30 Jun 23
Prospectus supplement for primary offering
8:42am
10-QT
htlyd
5 Jun 23
Quarterly report for transitional period
4:05pm
8-K
90il9itk zh
22 May 23
Regulation FD Disclosure
7:00am
424B5
7qi7wy2j md3
29 Dec 22
Prospectus supplement for primary offering
5:03pm
8-K
EX-10.1
ymqtc6c9cm7e6l
29 Dec 22
Entry into a Material Definitive Agreement
4:06pm